Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > Articles online first > The Journal of Cardiovascular Surgery 2016 Nov 23

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti
Per citare questo articolo

THE JOURNAL OF CARDIOVASCULAR SURGERY

Rivista di Chirurgia Cardiaca, Vascolare e Toracica


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,179


eTOC

 

The Journal of Cardiovascular Surgery 2016 Nov 23

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Single center experience with vascular closure devices in real-world endovascular peripheral interventions

Bruno FREITAS, Sabine STEINER, Yvonne BAUSBACK, Holger STAAB, Daniela BRANZAN, Ursula BANNING-EICHENSEER, Andrej SCHMIDT, Dierk SCHEINERT

Division of Interventional Angiology, University Hospital Leipzig, Leipzig, Germany


PDF  


BACKGROUND: To evaluate the efficacy and safety of vascular closure devices(VCDs) in non-cardiac endovascular interventions.
METHODS: Retrospective analysis of consecutive patients submitted to endovascular interventions, with deployment of 2327 vascular closure devices. Demographic, clinical/periprocedural, post-operative, complication and reintervention data were reviewed.
RESULTS: 2107 patients (1409(66.9%) men) were included. Perclose ProGlide®(Abbott Vascular, CA,USA) was employed 1683 times(72.3%), Angio- SealTM(St. Jude Medical Inc.,MN,USA) 463(19.9%) and 181(7.8%) Exoseal®(Cordis,NJ,USA). Patients were 70.4±11 years old. Vascular approaches were 1794 retrograde(77.1%) and 533 antegrade(22.9%), with sheath size ranging from 5- to 8-French. Overall success rate was 95.2% and did not significantly vary according to the device. Overall failure rate was 4.8%, with high puncture site, morbid obesity, previous total anticoagultion and severe calcification being related to worse efficiency results. Major complications occurred in 15 patients(0.6%). All patients were evaluated before discharge from the hospital, and were scheduled to return for ambulatory follow-up visits at 30 days postoperatively. Control duplex ultrasonography was performed on a regular basis, or within this period in case of clinical complain/signs.
CONCLUSIONS: Vascular closure devices proved to be safe and effective in this study. Additional prospective randomized studies are recommended.

inizio pagina

Publication History

Per citare questo articolo

Freitas B, Steiner S, Bausback Y, Staab H, Branzan D, Banning-Eichenseer U, et al. Single center experience with vascular closure devices in real-world endovascular peripheral interventions. J Cardiovasc Surg 2016 Nov 23. 

Corresponding author e-mail

brunofreitas@saudevascular.com